Primotec (PRMG)

Executive Summary

 

Primo-tech is a manufacturer and distributor of cleaning, paper, and nylon items. The company has recently (2023-Q4) experienced a significant increase in earnings due to the conflict in Israel, due to the Israeli Defense Forces (IDF) being its largest customer. With an equity multiple of 83% and current price to earnings ratio of 5.6, it appears that the market may be undervaluing the company. Our analysis indicates a potential upside of 15-50% in the forthcoming year.

 

About Primo-tech

 

Primo-tech is a manufacturer, importer and distributer of a wide range of cleaning products, paper products, nylon products, single-use products, cosmetics and related medical and geriatric equipment. The company distributes about 2,500 products to approximately 5,400 customers.

 

Below is the group’s sales distribution among the sectors:

 

 

Primo’s largest client is the Israeli defense forces (IDF). The spike in sales in 2023 is mainly due to the war that began in the middle east in the 4th quarter of 2023.  The company finished 2023 with a profit of ~25 million NIS, 15 of which in the 4th quarter alone!

 

Below is a graph summarizing Primo’s sales and gross profit margins:

 

 

Competition

 

Despite facing intense competition, Primo-tech maintains a modest market share. Unlike its rivals who prioritize retail customers and brand recognition, Primo-tech focuses on serving institutional clients such as governmental offices, hospitals, municipalities, and hotels. Retail clients contribute to only approximately 15% of Primo-tech’s overall sales.

 

Management

 

The combined ownership stake of the chairman and chief executive officer accounts for approximately 80% of the company.  This ownership stake, coupled with an effective incentive system that rewards management based on profitability targets, fosters a strong alignment of interests between the management team and minority shareholders.

 

Catalysts

 

There are three factors that are anticipated to drive value creation in the near future:

 

Firstly, the ongoing war in Israel has resulted in high demand for the company’s products, particularly due to the Israeli Defense Forces (IDF) being its largest customer. As long as the war persists, it is reasonable to expect that the company will achieve record-breaking revenues and profits in 2024.

 

Secondly, the company has nearly completed the establishment of a new manufacturing and logistics facility, as well as new offices. These investments took a toll on the company’s ability to generate free cash flow.  Since these investments are coming to an end, we can expect the company to significantly increase its capacity to generate free cash flows (see graph below, showing historical levels of profits and free cash flows).

 

 

Lastly, as of April 14th, Primo-tech is currently trading at 141.2 million NIS, with equity valued at 169.9 million NIS (equity multiple of 0.83%), and a price to earnings ratio of 5.6.  In comparison, the leading company in the field, Sano, trades at an equity multiple of 2.25 and an earnings multiple of 18. While Primo-tech is not deserving a valuation on par with the industry leader, the current valuation appears to offer a satisfactory margin of safety and potential for growth if the market recognizes the disparity and potential of Primo-tech.

 

Considering the present favorable market conditions and the undervaluation of Primo-tech, we anticipate a potential increase of 15-50% within the next year.

 

 

The information contained herein is provided for informational purposes only, is not comprehensive, does not contain important disclosures and risk factors associated with investments, and is subject to change without notice. The author is not responsible for the accuracy, completeness or lack thereof of information, nor has the author verified information from third parties which may be relied upon. The information does not take into account the particular investment objectives or financial circumstances of any specific person or organization which may view it. The author is not a registered investment advisor and does not represent the information as a recommendation for readers to buy or sell the securities under discussion. Nothing contained within may be considered an offer or a solicitation to purchase or sell any particular financial instrument. All liability for the content of this information, including any omissions, inaccuracies, errors, or misstatements is expressly disclaimed. Always complete your own due diligence. Before making any investment, investors are advised to review such investment thoroughly and carefully with their financial, legal and tax advisors to determine whether it is suitable for them. The author may have a position in the mentioned securities and may buy or sell any security mentioned without notice. Investing in the mentioned securities is dangerous and may cause a loss of the entire invested capital. If you act according to information presented in this site you bear sole responsibility for the results of these actions, the author shall not be held responsible for any such action whatsoever. All trademarks and logos displayed on this website are the property of their respective owners.

More To Explore